000 | 01229 a2200349 4500 | ||
---|---|---|---|
005 | 20250514183025.0 | ||
264 | 0 | _c20041208 | |
008 | 200412s 0 0 eng d | ||
022 | _a0041-1345 | ||
024 | 7 |
_a10.1016/j.transproceed.2004.01.059 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAugustine, J J | |
245 | 0 | 0 |
_aExperience with everolimus. _h[electronic resource] |
260 |
_bTransplantation proceedings _cMar 2004 |
||
300 |
_a500S-503S p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aEverolimus |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xchemistry |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransplantation Immunology |
700 | 1 | _aHricik, D E | |
773 | 0 |
_tTransplantation proceedings _gvol. 36 _gno. 2 Suppl _gp. 500S-503S |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2004.01.059 _zAvailable from publisher's website |
999 |
_c14758560 _d14758560 |